How to define responders in osteoarthritis.

How to define responders in osteoarthritis.

BACKGROUND: Osteoarthritis is a clinical syndrome of failure of the joint accompanied by varying degrees of joint pain, functional limitation, and reduced quality of life due to deterioration of articular cartilage and involvement of other joint structures. SCOPE: Regulatory agencies require releva...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Cooper, C, Adachi, J, Bardin, T, Berenbaum, F, Flamion, B, Jonsson, H, Kanis, J, Pelousse, F, Lems, W, Pelletier, J, Martel-Pelletier, J, Reiter, S, Reginster, J, Rizzoli, R, Bruyère, O
Formato:	Journal article
Idioma:	English
Publicado em:	2013

Registos relacionados

An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Por: Bruyère, O, et al.
Publicado em: (2014)

Value of biomarkers in osteoarthritis: current status and perspectives.
Por: Lotz, M, et al.
Publicado em: (2013)

Republished: Value of biomarkers in osteoarthritis: current status and perspectives.
Por: Lotz, M, et al.
Publicado em: (2014)

A reference case for economic evaluations in osteoarthritis: An expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Por: Hiligsmann, M, et al.
Publicado em: (2014)

Osteoarthritis: The Challenge of Establishing a Personalised Treatment
Por: Johanne Martel-Pelletier, et al.
Publicado em: (2014-06-01)

WHAT IS THE PREDICTIVE VALUE OF MRI FOR THE OCCURRENCE OF HARD CLINICAL ENDPOINTS IN KNEE OSTEOARTHRITIS?
Por: Pelletier, J, et al.
Publicado em: (2013)

Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis.
Por: Bruyère, O, et al.
Publicado em: (2014)

HEALTH ECONOMICS IN OSTEOARTHRITIS
Por: Hiligsmann, M, et al.
Publicado em: (2013)

What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis?
Por: Pelletier, J, et al.
Publicado em: (2013)

Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Por: Hiligsmann, M, et al.
Publicado em: (2013)

STRONTIUM RANELATE PREVENTS RADIOLOGICAL PROGRESSION IN PATIENTS WITH PRIMARY KNEE OSTEOARTHRITIS: A RESPONDERS ANALYSIS
Por: Cooper, C, et al.
Publicado em: (2013)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
Por: Bruyère, O, et al.
Publicado em: (2008)

Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Por: Rizzoli, R, et al.
Publicado em: (2013)

Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients
Por: Guangju Zhai, et al.
Publicado em: (2019-11-01)

Challenges for the development of bone-forming agents in Europe
Por: Kanis, J, et al.
Publicado em: (2014)

Challenges for the development of bone-forming agents in Europe.
Por: Kanis, J, et al.
Publicado em: (2014)

MULTICENTRIC OSTEOARTHRITIS INTERVENTION STUDY WITH SYSADOA (MOVES): EFFECTS OF COMBINED GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE VS. CELECOXIB FOR PAINFUL KNEE OSTEOARTHRITIS
Por: Castillo, JR, et al.
Publicado em: (2014)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Por: Rizzoli, R, et al.
Publicado em: (2011)

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.
Por: Rizzoli, R, et al.
Publicado em: (2011)

Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
Por: Cooper, C, et al.
Publicado em: (2012)

Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system
Por: Rizzoli René, et al.
Publicado em: (2008-12-01)

Is there a mitochondrial DNA haplogroup connection between osteoarthritis and elite athletes? A narrative review
Por: Jean-Pierre Pelletier, et al.
Publicado em: (2022-09-01)

Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
Por: Reginster, J, et al.
Publicado em: (2012)

EFFECT OF STRONTIUM RANELATE ON KNEE PAIN IN OSTEOARTHRITIS: A RESPONDER ANALYSIS
Por: Cooper, C, et al.
Publicado em: (2013)

A reappraisal of generic bisphosphonates in osteoporosis.
Por: Kanis, J, et al.
Publicado em: (2012)

Health technology assessment in osteoporosis.
Por: Hiligsmann, M, et al.
Publicado em: (2013)

Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
Por: Bruyere, O, et al.
Publicado em: (2013)

Mesenchymal Stromal Cell Immunology for Efficient and Safe Treatment of Osteoarthritis
Por: Mehdi Najar, et al.
Publicado em: (2020-09-01)

Magnetic resonance imaging assessments for knee segmentation and their use in combination with machine/deep learning as predictors of early osteoarthritis diagnosis and prognosis
Por: Johanne Martel-Pelletier, et al.
Publicado em: (2023-04-01)

Changes in structure and symptoms in knee osteoarthritis and prediction of future knee replacement over 8 years.
Por: Bruyere, O, et al.
Publicado em: (2013)

STRONTIUM RANELATE PREVENTS SPINE OSTEOARTHRITIS PROGRESSION IN PATIENTS WITH PREVALENT SPINAL OSTEOARTHRITIS
Por: O Bruyere, et al.
Publicado em: (2007-08-01)

Partial adherence: a new perspective on health economic assessment in osteoporosis.
Por: Kanis, J, et al.
Publicado em: (2011)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Por: Kanis, J, et al.
Publicado em: (2008)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (Osteoporosis International DOI: 10.1007/s00198-008-0560-z)
Por: Kanis, J, et al.
Publicado em: (2008)

The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).
Por: Rizzoli, R, et al.
Publicado em: (2014)

Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate
Por: Reginster, J, et al.
Publicado em: (2013)

Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
Por: Bruyere, O, et al.
Publicado em: (2012)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Por: Kanis, J, et al.
Publicado em: (2013)

European guidance for the diagnosis and management of osteoporosis in postmenopausal women (vol 19, pg 399, 2008)
Por: Kanis, J, et al.
Publicado em: (2008)

Common Biochemical and Magnetic Resonance Imaging Biomarkers of Early Knee Osteoarthritis and of Exercise/Training in Athletes: A Narrative Review
Por: Johanne Martel-Pelletier, et al.
Publicado em: (2021-08-01)